37.5 million for a consortium of regenerative medication | MedNet

The DRIVE-RM consortium will obtain 37.5 million euros from the Summit grant from NWO. The cash will probably be spent on analysis into tissue-driven regeneration of broken tissues and organs, with the intention of bettering the remedy of kidney failure, amongst different issues.

The interdisciplinary DRIVE-RM staff is led by internist-nephrologist Marianne Verhaar, professor of Experimental Nephrology at UMC Utrecht. Utrecht College, TU Eindhoven, Maastricht College and the Hubrecht Institute are additionally a part of the consortium.

DRIVE-RM makes use of clever, dwelling and typically dwelling supplies that stimulate the human physique to create new tissue. The consortium will incorporate earlier improvements from the 5 collaborating establishments, corresponding to organoids and 4D bioprinting. By working collectively, scientists acquire new insights into controlling regenerative processes, from single cells to entire organs. This might enhance the remedy of power ailments sooner or later, corresponding to kidney failure, coronary heart failure and ailments of bones, cartilage and joints.

The Summit program, from which the grant originated, facilitates scientific advances on a worldwide scale. The Summit grant is a 10-year funding of a complete of 174 million euros, which is split amongst 5 analysis consortia of Dutch universities.

Sources:

NWO & UMC Utrecht